Pediatric Blood & Cancer · 2009 · 29 citations · 26 references
MedicineMolecular GeneticsOncologyCancer GeneticsHepatologyMolecular OncologyHepatobiliary CancerHepatocellular CarcinomaLiver CancerLiver DiseasePediatric TumorsTumor HistopathologyCancer Cell Line ModelsCell Line IsolationEmbryonal Tumor PathologyHepatic MalignancyHepatic TumorsPrimary Liver CancerPrimary Tumor Characterization
BACKGROUND: Hepatoblastoma is a rare malignancy of childhood. The scarcity of adequate cell models has limited our understanding of this tumor. Here we describe and characterize a new human liver tumor cell line, Hep293TT, derived from an aggressive childhood hepatoblastoma. PROCEDURES: Hep293TT cells were established using primary tumor tissues from a 5-year-old Caucasian female child. This cell line has been maintained for more than 34 months and over 20 subcultures, and was characterized by histopathology, ELISA, genotype, cytogenetics, CGH array, immunohistochemistry, and molecular sequence analyses. RESULTS: Cells were confirmed to originate from parental tumor cells, secrete alpha-fetoprotein, and express hepatic markers and beta-catenin. Hep293TT cells were able to form colonies in soft agar. Tumorigenicity was demonstrated by induction of solid tumors after subrenal capsule injection in immunodeficient mice. Hep293TT cells demonstrated a highly aneuploid karyotype, and a whole genome CGH analysis revealed chromosomal imbalances in every chromosome. Allelotype analysis demonstrated loss of alleles at distal 11p15.5 as is typical of embryonal tumors. Both Hep293TT cells and the primary tumor contain a deletion of 351 nucleotides in beta-catenin, as has been seen in other hepatoblastoma tumors. The cell line expressed beta-catenin protein in both full-length and partially deleted forms, and expressed NOTCH2 protein characteristic of hepatoblasts. No mutation was detected in the APC, MYH, MLH1, or MSH2 genes. CONCLUSION: This cell line, Hep293TT, is a valuable resource for the study of childhood liver cancer and may potentially provide a tool in the development of new agents.
26
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
David P. Aden, Alice Fogel, Stanley A. Plotkin et al. · Nature · 1979 · 1.3K citations
Medicine, Biochemistry, Oncology +5
Anne Koch, Dorota Denkhaus, Steffen Albrecht et al. · PubMed · 1999 · 403 citations
Life Sciences, Genetics, Oncology +17
Mitsuo Sato, Melville B. Vaughan, Luc Girard et al. · Cancer Research · 2006 · 266 citations
Medicine, Cell Biology, Oncology +17
Hepatoblastoma and APC gene mutation in familial adenomatous polyposis.
Francis M. Giardiello, Gloria M. Petersen, Jill D. Brensinger et al. · Gut · 1996 · 166 citations · Full text